Xilio Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that René Russo,
atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference
NEW YORK and BERLIN, Feb. 24, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage
Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference
A live audio webcast of the presentation will be available under "Events & Presentations” in the News & Events section of the Company's website at www.primemedicine.com. A replay of the webcast will be available on the Prime Medicine website for 30 days following the presentation.
MediWound to Present at the 45th Annual TD Cowen Health Care Conference
MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that Chief Executive Officer Ofer Gonen will present a corporate overview at the upcoming 45th Annual TD Cowen Health Care Conference,
Bicara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
A live webcast of the presentation will be available at Events and Presentations. A replay of the webcast will be archived and available following the event.
Morningstar3d
agilon health to Participate in TD Cowen’s 45th Annual Health Care Conference
announced that it will participate in the 45th Annual TD Cowen Healthcare Conference including a fireside chat presentation on Wednesday, March 5 at 9:50 AM Eastern Time. Interested investors and ...
BeiGene to Present at Upcoming Investor Conferences
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the Company will participate in fireside ...